Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
ACS Infectious Diseases
|
April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
Masanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Immunity
|
April 10, 2012
The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments
Jian-Guo Zhang, Peter E Czabotar, Antonia N Policheni, et al.
The Lancet. Microbe
|
January 13, 2025
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study
Navin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-<i>b</i>]pyridines
Scott Eagon, Jared T Hammill, Martina Sigal, et al.
European Journal of Medicinal Chemistry
|
October 10, 2024
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b
Jon Kyle Awalt, Wenyin Su, William Nguyen, et al.
ACS Infectious Diseases
|
November 11, 2024
Tambjamines as Fast-Acting Multistage Antimalarials
Amrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Journal of Medicinal Chemistry
|
April 14, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4
Jon Kyle Awalt, Zi Kang Ooi, Trent D Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasome
Stanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Nature Communications
|
April 21, 2022
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
Laura E de Vries, Patrick A M Jansen, Catalina Barcelo, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
ACS Infectious Diseases
|
April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
Masanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Immunity
|
April 10, 2012
The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments
Jian-Guo Zhang, Peter E Czabotar, Antonia N Policheni, et al.
The Lancet. Microbe
|
January 13, 2025
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study
Navin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-<i>b</i>]pyridines
Scott Eagon, Jared T Hammill, Martina Sigal, et al.
European Journal of Medicinal Chemistry
|
October 10, 2024
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b
Jon Kyle Awalt, Wenyin Su, William Nguyen, et al.
ACS Infectious Diseases
|
November 11, 2024
Tambjamines as Fast-Acting Multistage Antimalarials
Amrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Science (New York, N.Y.)
|
June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy
Stanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Journal of Medicinal Chemistry
|
April 14, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4
Jon Kyle Awalt, Zi Kang Ooi, Trent D Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasome
Stanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Nature Communications
|
April 21, 2022
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
Laura E de Vries, Patrick A M Jansen, Catalina Barcelo, et al.
Page
of 14